EGFR and cervical carcinoma: However, combined treatment with verteporfin and AG1478 completely blocked the growth of ME180-YAPS127A cells on soft agar, suggesting that the combined targeting of the Hippo/YAP and EGFR pathways may be a more efficient way to inhibit cervical cancer cell growth (Fig8D).